Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Heterogeneous characteristics of lymphatic microvasculatures associated with pulmonary sarcoid granulomas.

Yamashita M, Mouri T, Niisato M, Kowada K, Kobayashi H, Chiba R, Satoh T, Sugai T, Sawai T, Takahashi T, Yamauchi K.

Ann Am Thorac Soc. 2013 Apr;10(2):90-7. doi: 10.1513/AnnalsATS.201209-078OC.

PMID:
23607836
2.
3.

Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland.

Fujita G, Sato S, Kishino M, Iwai S, Nakazawa M, Toyosawa S, Yura Y, Ogawa Y.

Mod Pathol. 2011 Jul;24(7):885-91. doi: 10.1038/modpathol.2011.42. Epub 2011 Mar 18.

4.
5.

Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.

Liu B, Ma J, Wang X, Su F, Li X, Yang S, Ma W, Zhang Y.

Anat Rec (Hoboken). 2008 Oct;291(10):1227-35. doi: 10.1002/ar.20736.

6.

Lymphatic and blood microvasculature organisation in pulmonary sarcoid granulomas.

Kambouchner M, Pirici D, Uhl JF, Mogoanta L, Valeyre D, Bernaudin JF.

Eur Respir J. 2011 Apr;37(4):835-40. doi: 10.1183/09031936.00086410. Epub 2010 Jul 22.

7.

Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.

Zhao YC, Ni XJ, Li Y, Dai M, Yuan ZX, Zhu YY, Luo CY.

World J Surg Oncol. 2012 Aug 20;10:165. doi: 10.1186/1477-7819-10-165.

8.
9.

Differential expression of VEGF ligands and receptors in prostate cancer.

Woollard DJ, Opeskin K, Coso S, Wu D, Baldwin ME, Williams ED.

Prostate. 2013 May;73(6):563-72. doi: 10.1002/pros.22596. Epub 2012 Oct 4.

PMID:
23038639
10.
11.

Molecular control of lymphatic metastasis.

Achen MG, Stacker SA.

Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Review.

PMID:
18519975
12.

Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.

Sun JG, Wang Y, Chen ZT, Zhuo WL, Zhu B, Liao RX, Zhang SX.

J Exp Clin Cancer Res. 2009 Feb 16;28:21. doi: 10.1186/1756-9966-28-21.

13.

Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.

Yonemura Y, Endo Y, Tabata K, Kawamura T, Yun HY, Bandou E, Sasaki T, Miura M.

Int J Clin Oncol. 2005 Oct;10(5):318-27.

PMID:
16247658
14.

The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.

Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Ylä-Herttuala S, Wedge SR, Jürgensmeier JM, Alitalo K.

Cancer Res. 2008 Jun 15;68(12):4754-62. doi: 10.1158/0008-5472.CAN-07-5809.

15.

Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.

Lohela M, Heloterä H, Haiko P, Dumont DJ, Alitalo K.

Am J Pathol. 2008 Dec;173(6):1891-901. doi: 10.2353/ajpath.2008.080378. Epub 2008 Nov 6.

16.

Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.

Ji RC, Miura M, Qu P, Kato S.

Microsc Res Tech. 2004 Jun 15;64(3):279-86.

PMID:
15452895
17.

Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients.

Tzouvelekis A, Ntolios P, Karameris A, Koutsopoulos A, Boglou P, Koulelidis A, Archontogeorgis K, Zacharis G, Drakopanagiotakis F, Steiropoulos P, Anevlavis S, Polychronopoulos V, Mikroulis D, Bouros D.

BMC Res Notes. 2012 Nov 26;5:654. doi: 10.1186/1756-0500-5-654.

18.

Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.

Onofri C, Losa M, Uhl E, Stalla GK, Renner U.

Exp Clin Endocrinol Diabetes. 2008 Mar;116(3):152-7. doi: 10.1055/s-2007-992120. Epub 2008 Jan 18.

PMID:
18205092
19.
20.

Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.

Feng Y, Wang W, Hu J, Ma J, Zhang Y, Zhang J.

Anat Rec (Hoboken). 2010 May;293(5):802-12. doi: 10.1002/ar.21096.

Supplemental Content

Support Center